血管内介入联合中药治疗中晚期肝癌临床疗效比较  

Clinical efficacy study of TAI/TACE combined with traditional Chinese medicine in treating advanced hepatoma

作　　者：念丁芳[1] 芦连菊 周军[1] 李文华[1] 曹庆选[1] 

机构地区：[1]青岛海慈医疗集团医学影像中心,山东青岛266033 [2]青岛市海慈医疗集团中医院肿瘤科,山东青岛266033

出　　处：《中国中西医结合影像学杂志》2005年第4期262-264,共3页Chinese Imaging Journal of Integrated Traditional and Western Medicine

摘　　要：目的:比较血管内介入栓塞术(TAI/TACE)与联合中药治疗中晚期肝癌的临床效果。方法:将186例失去手术机会的中晚期肝癌患者,随机分成两组进行治疗,一组(A组)90例,行经导管动脉化疗栓塞术,另一组(B组)96例,在进行经导管动脉化疗栓塞术的同时,给予系统的中医药治疗,治疗全程对患者的生存率、生活质量进行半年、1、2、3、4、5年的随访。结果:两组患者术后半年、1、2、3、4、5年的生存率分别为92.5%、80.6%、48.3%、21.5%、8%、2.2%与96.8%、88.7%、67.2%、35.5%、15%、4.2%,B组生存率明显高于A组。生存期内,B组患者的生活质量明显好于A组患者。结论:血管内介入栓塞术与中医药治疗的联合应用,可明显延长患者的生存期与提高患者的生活质量。Objective： To cvaluate the clinical efficacy of advanced hepatoma by comparing TAI/TACE with TAI/TACE combined with traditional Chinese medicine. Methods： One hundred and eighty-six cases of advanced hepatoma,who had lost opportunity of operation,were divided into two groups randomly： group A and group B. There were 90 cases in group A and 96 cases in group B,the cases of group A were treated with TA1/TACE,the cases of group B were treated witb TAI/TACE combined with traditional Chinese medicine meanwhile. All cases were followed-up in half, one, two. three, four, five years on exist rate and life qualily. Results： The exist rate of group A and group B in half. one, two, three, four, five years were 92.5%,80.6%,48.3%,21.5%.8%,2.2% and 96.8%,88. 7%,67. 2%,35. 5%,15%0,4. 2% respectively, the life quality of group B was obviously better than group A during existence. Conclusion： TAI/TACE combined with traditional Chinese medicine could obviously prolong the existence and improve the life quality.

关 键 词：经动脉导管化疗 栓塞术(TAI/TACE) 中医药 中晚期肝瘤 

分 类 号：R735.7[医药卫生—肿瘤]